INVESTOR ALERT: Berger Montague Advises Hims & Hers Health Inc. (NYSE: HIMS) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025
Berger Montague announces a securities fraud investigation into Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) concerning potential violations of the Securities Exchange Act of 1934. The inquiry focuses on whether investors were misled about the Company's regulatory compliance and business operations. https://mma.prnewswire.com/media/232479/berger_montague.jpg Following Novo Nordisk's termination of its collaboration […]